Data set | Procedure | What's in this data set | Panel | Sex | Age (weeks) | Year |
---|---|---|---|---|---|---|
|
body weight
with high-fat high-sucrose diet |
Weekly. | DO population | both | 4-26wks | 2018 |
|
body weight
with high-fat diet |
8-29 wks of age. | BXD w/par (57) | m | 8-29 wks | 2016 |
|
body weight
with high-fat diet |
inbred w/CC8 | both | 8-21 wks | 2021 | |
|
body weight | Body weight | inbred (13) | m | 7-8wks | 2011 |
|
body weight | Body weight and growth curve from 4wks to 26wks weighed monthly. | ILSXISS (97) | f | 6wks | 2005 |
|
body weight | Body weight | both | 8-20wks | 2021 | |
|
body weight
with influenza A (H5N1) virus |
Influenza A (H5N1) virus (several doses) vs. baseline. | inbred (23) | f | 6-9wks | 2011 |
|
body weight
with Theiler's murine encephalomyelitis virus |
Body weight | CC (5) | both | 4wks | 2017 |
|
body weight | Body weight | inbred (14) | both | 10wks | 2004 |
|
body weight | Body weight | CC diallel w/par (62) | both | 8-16wks | 2012 |
|
body weight | Body weight | DO population w/par (9) | both | 12-16wks | 2013 |
|
body weight
with high-fat diet |
Body weight and growth curve from age 1wk to 22wks (pre-wean, post-wean, adult). High-fat diet (17wks) vs. control. | LGXSM w/par (19) | both | 12-16wks | 2004 |
|
body weight
with ethanol |
Body weight | inbred (8) | both | 8wks | 2003 |
|
body weight
with ethanol |
Body weight | inbred (22) | both | 9-17wks | 2003 |
|
body weight
with haloperidol |
Baseline vs. after haloperidol 60d implant. | inbred w/CC8 (27) | m | 9-28wks | 2012 |
|
body weight | Body weight | BXD w/par (55) | both | 10-16wks | 2018 |
|
body weight | Body weight | inbred (13) | both | 10wks | 2004 |
|
body weight | Body weight | BXD w/par (66) | both | 10wks | 2010 |
|
body weight | Pup body weight at day 3. | inbred (15) | f | 6-8wks | 2010 |
|
body weight | Pup body weight at day 3. | B6.A consomic w/par (22) | f | 6-8wks | 2010 |
|
body weight | Body weight | inbred (10) | both | 16wks | 2004 |
|
body weight | Body weight | inbred (14) | both | 9-12wks | 2003 |
|
body weight | Body weight | inbred (14) | both | 25wks | 2009 |
|
body weight
with influenza A (H1N1) virus |
Body weight | CC pre w/par (163) | f | 8-16wks | 2012 |
|
body weight | Body weight and growth curve from 8wks to 21wks. | inbred w/CC8 (8) | both | 8-21wks | 2020 |
|
body weight
with West Nile virus |
Body weight | CC RIX (5) | m | 8-10wks | 2015 |
|
body weight | Body weight of newborns. | inbred (8) | both | postnatal | 2011 |
|
body weight | Body weight of newborns. | BXH (10) | both | postnatal | 2011 |
|
body weight | Daily body weight gain of cross-fostered pups. | inbred (31) | f | 14-18wks | 2012 |
|
body weight | Body weight | DO population | both | 8-60 wks | 2020 |
|
body weight | Body weight | inbred (14) | m | 8-10wks | 2010 |
|
body weight
with isoniazid |
Body weight. Isoniazid-treated vs. control. | inbred (34) | f | 8-10wks | 2011 |
|
body weight
with DB289 |
DB289-treated vs. control. | inbred (34) | f | 6-8wks | 2012 |
|
body weight
with (R/S)-1,3-butanediol, 17-a-estradiol, 17-dimethylaminoethylamino-17-demethoxygeldanamycin hydrochloride, 2-(2-Hydroxyphenyl)benzoxazole, 3-(3-hydroxybenzyl)-5-methylbenzo[d]oxazol-2(3H)-one, 4-OH-a-phenyl-N-tert-butyl nitrone, 4-phenylbutyrate, acarbose, aspirin, astaxanthin, b-guanidinopropionic acid, caffeic acid phenethyl ester, canagliflozin, captopril, candesartan cilexetil, curcumin, dimethyl fumarate, enalapril, fisetin, fish oil, geranylgeranyl acetone, glycine, green tea extract, INT-767 FXR/TGR5 agonist, inulin, L-Leucine, meclizine, medium-chain triglyceride, metformin, metformin plus rapamycin, methylene blue, minocycline, MitoQ, mycophenolic acid, nicotinamide riboside, nitroflurbiprofen, nordihydroguaiaretic acid, oxaloacetic acid, PB125, protandim, rapamycin, rapamycin plus acarbose, resveratrol, SG1002, simvastatin, sulindac, syringaresinol, TM5441, ursodeoxycholic acid, ursolic acid, 16-a-hydroxyestriol, 2,4-dinitrophenol, a-Ketoglutarate, Hydralazine, Nebivolol, Sodium thiosulfate |
Various interventions vs. controls. | UM-HET3 population | both | various | 2004-2024 |
|
body weight | Body weight and growth curve from age 3wks to 10 wks, weighed weekly. | inbred (24) | both | 8wks | 2000 |
|
body weight | Body weight | inbred (11) | both | 8, 16 wks | 2006 |
|
body weight | Body weight | inbred (11) | both | 8, 16 wks | 2006 |
|
body weight | Body weight and growth curve from age 3wks to 16wks, weighed weekly. | inbred (10) | both | 3-16wks | 2014 |
|
body weight | Body weight | inbred (11) | both | 8, 16 wks | 2006 |
|
body weight | Body weight | inbred (7) | both | 8-14wks | 2003 |
|
body weight | Body weight | inbred w/CC8 (62) | both | 8-14wks | 2021 |
|
body weight | Body weight | CC pre (31) | both | 8-14wks | 2015 |
|
body weight | Body weight | inbred (41) | both | 8-9wks | 2010 |
|
body weight
with exercise |
Exercise (swim endurance training regimen) vs. control at weekly intervals for 5wks. | inbred (6) | m | 11-14wks | 2012 |
|
body weight | Body weight | CC (16) | both | 10wks | 2015 |
|
body weight | Body weight | inbred (34) | both | 8wks | 2012 |
|
body weight
with exercise |
Baseline vs. after exercise (access to running wheel). | CC pre w/par (184) | m | 10-12wks | 2011 |
|
body weight
with atenolol, isoproterenol |
Isoproterenol or atenolol vs. control. | inbred (23) | m | 10-12wks | 2009 |
|
body weight | Body weight | CC (50) | f | 17-72wks | 2017 |
|
body weight | Body weight before, during, and after several weeks of exercise. | CC (43) | f | 20-88wks | 2017 |
|
body weight
with exercise |
Body weight before and after 2 weeks of exercise wheel availability. | CC (13) | f | 32-40wks | 2018 |
|
body weight
with exercise |
Body weight before and after 4 weeks of treadmill-based exercise training. 3 intensity cohorts. | CC (4) | both | 8-10wks | 2018 |
|
body weight
with ethanol |
Body weight | inbred (15) | m | 8-11wks | 2005 |
|
body weight | Body weight | CC (52) | m | 7-20wks | 2018 |
|
body weight
with high-fat diet and olanzapine |
Body weight and growth curve from age 8wks to 18wks weighed every 2wks. Olanzapine vs. control (both groups high-fat diet). | inbred w/CC8 (9) | f | 8-18wks | 2014 |
|
body weight
with high-fat diet |
Baseline vs. high-fat diet for 12wks. | B6.A consomic w/par (24) | m | 5, 17 wks | 2008 |
|
body weight
with high-fat high-sucrose diet |
After 16 wks on high-fat high-sucrose diet. | inbred (2) | m | 21 wks | 2016 |
|
body weight
with high-fat high-sucrose diet |
High-fat high-sucrose diet for 14-15 wks | B6.A consomic w/par (3) | m | 4-19 wks | 2016 |
|
body weight
with high-fat diet |
High-fat diet for 8wks. | inbred w/CC7 (43) | both | 5, 21 wks | 2003 |
|
body weight
with restricted diet |
Restricted diet vs. ad libitum diet. | ILSXISS (44) | both | max lifespan | 2010 |
|
body weight | Measured every 2 mo, starting at age 2 mo to 16 mo. | F1 AD-BXD (55) | both | 7-65wks | 2019 |
|
body weight | Body weight | inbred (8) | m | 10-66wks | 2015 |
|
body weight
with high-fat diet |
Baseline vs. high-fat diet for 8wks. | inbred (44) | both | 15-19wks | 2000 |
|
body weight
with high-fat diet |
Baseline vs. high-fat diet for 8wks. | obesity mutants (8) | both | 15-19wks | 2000 |
|
body weight | Body weight | F1 Tcf7l2 (30) | both | 7-14wks | 2017 |
|
body weight
with methamphetamine |
Body weight | F1 Cacna1c (30) | both | 7-14wks | 2017 |
|
body weight | Body weight | F1 Tcf7l2 (30) | both | 7-14wks | 2017 |
|
body weight
with methamphetamine |
Body weight | F1 Cacna1c (30) | both | 7-14wks | 2017 |
|
body weight | Body weight | inbred (32) | m | 7-9wks | 2007 |
|
body weight
with exercise |
Exercise wheel group vs. control group. | inbred (12) | both | 8-15wks | 2010 |
|
study archive
with tetrachloroethylene |
Toxicokinetics and toxicodynamics of tetrachloroethylene exposure. | CC (45) | both | 2016 | |
|
body weight
with various diets |
Body weight at weaning and time of test. Comparison of 4 diets. | CC RIX (18) | f | 8-9 wks | 2018 |
|
body weight | Body weight | inbred (11) | both | 8-10wks | 2005 |
|
body weight
with high-fat diet |
At 8, 20 and 29 wks of age. | BXD w/par (36) | m | 8-29 wks | 2022 |
|
body weight
with influenza A (H1N1) virus |
Influenza A (H1N1) virus vs. baseline. Several timepoints. | inbred (9) | both | 10-12wks | 2009 |
|
body weight
with influenza A (H1N1) virus |
Influenza A (H1N1) virus vs. baseline. Several timepoints.. | BXD w/par (56) | f | 9-18wks | 2012 |
|
body weight
with influenza A (H3N2) virus |
Influenza A (H3N2) virus (several doses) vs. baseline. Several timepoints. | inbred w/CC8 (8) | both | 7-13wks | 2013 |
|
body weight
with influenza A (H3N2) virus |
Influenza A (H3N2) virus vs. controls. Several timepoints. | inbred w/CC8 (8) | f | 8-12wks | 2016 |
|
body weight
with influenza A (H3N2) virus |
Influenza A (H3N2) virus vs. controls. Several timepoints. | inbred w/CC8 (8) | f | 8-12wks | 2016 |
|
body weight | Body weight | inbred (7) | both | 9-18wks | 2000 |
|
body weight | Body weight | inbred (16) | both | 7-9wks | 2001 |
|
body weight
with high-fat diet |
High-fat diet for 4wks vs. control. | inbred (10) | both | 10-13wks | 2008 |
|
body weight | Body weight | CC (12) | m | 15-33wks | 2020 |
|
body weight | Body weight | CC RIX (28) | m | 7-44wks | 2020 |
|
body weight | Body weight | DO population | m | 12-15wks | 2020 |
|
body weight
with selenium |
Body weight curve 3 to 12 wks, control group. | inbred w/CC8 (8) | m | 3-14wks | 2018 |
|
body weight
with cocaine |
Body weight | inbred (45) | m | 8-11wks | 2015 |
|
body weight | Body weight during testing. | inbred (28) | m | 9wks | 2001 |
|
body weight | Body weight | inbred (28) | m | 4-12wks | 2001 |
|
body weight | Body weight | inbred w/CC7 (40) | both | 9-15wks | 2002 |
|
body weight | Body weight | ILSXISS (43) | both | 8-23wks | 2015 |
|
body weight | Body weight | inbred (21) | both | 6-8wks | 2009 |
|
body weight | Body weight | inbred w/CC7 (40) | both | 5-6wks | 2002 |
|
body weight | Body weight | CC RIX (73) | both | 7-13wks | 2020 |
|
body weight
with arsenic |
Baseline, then after iAs exposure for 26 wks | DO population | m | 4-34 wks | 2022 |
|
body weight | Aging study, 6mo, 12mo, and 18mo. | inbred (33) | both | 26, 52, 78 wks | 2007 |
|
body weight | inbred (30) | both | 7-15 wks | 2020 |